IL17A and ovarian carcinoma: SNAI2/Slug [35,40,43,54,58,62,73,74,76], and SNAI1/Snail [35,41,43,54,58,61,62,64,72,74,76] have been reported to be upregulated by treatment with TGF-β and BMP [42] as well as by treating ovarian cancer cells with IL-17 [38], chemokine CCL5 [67], and CCL19/CXCR7 [68,69].